Ensysce Biosciences, Inc. (NASDAQ: ENSC) has completed the acquisition of privately held Cy Biopharma, Inc., a clinical-stage biotechnology company developing ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions